Nebenwirkungen · Kaletra
Kaletra 200 mg/50 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 62–63
HOS-109031 · Präparat HOS-093083
62 The following events have been identified as adverse reactions. The frequency category includes all reported events of moderate to severe intensity, regardless of the individual causality assessment. The adverse reactions are displayed by system organ class. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness: very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1000 to < 1/100), rare (≥1/10 000 to <1/1000) and not known (cannot be estimated from the available data).
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-12-02T16:00:00Z · SHA-256 441d9e5f9e4b42d645e4bd802abc892cef6574b0be5b3f18d2a96678774ae365 · Passage 4fe2301ff6b0e29cc144747b43ebad76f5ce2b064ad3207c5470b97d51ba1d3d · Zeichen 1320–1855 im Abschnitt